Key result
Pulmonary metastasectomy shows no proven survival benefit over natural history for metastatic soft tissue sarcomas.
Why the study?
The impact of pulmonary metastasectomy on survival in metastatic soft tissue sarcomas is unclear due to lack of prospective studies with appropriate control groups.
Does pulmonary metastasectomy improve survival in patients with metastatic soft tissue sarcomas?
Does pulmonary metastasectomy improve survival in patients with metastatic soft tissue sarcomas?
Answers are grounded in this paper and cite their sources.
The available literature does not provide sufficient evidence to justify aggressive pulmonary metastasectomy for soft tissue sarcomas, highlighting the need for randomized prospective studies.
The role of pulmonary metastasectomy for metastatic soft tissue sarcomas is examined by reviewing the recent (1978-1994) English language literature. There are no prospective studies that contain an appropriate control group, and only one retrospective study contains a matched control group. In those few studies that provide greater than 5-year survival data, the survival curve still has a steep slope and few patients are alive at 7 years. In most studies only one or two patients are at risk at 5 years or more. Projected survival is therefore statistically questionable. It is currently impossible to know what is the impact of the surgical procedure over and above the natural history (biology) of the tumor. A randomized, prospective study, as suggested a decade ago, is still needed. While there may be some merit to pulmonary metastasectomy in highly selected patients, aggressive pulmonary metastasectomy does not seem justified by the available data.
No takes yet. Share an insight, caveat, or question.
Daniel B. Frost (1995) conducted a review in Metastatic soft tissue sarcomas. Pulmonary metastasectomy was evaluated on Survival. Aggressive pulmonary metastasectomy for metastatic soft tissue sarcomas does not seem justified by available data, as survival benefits over the natural history of the tumor remain unproven.
Synapse has enriched 10 related papers. Consider them for comparative context: